Business
Cardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores
Cardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores.
About this update from Cardax Inc
[{"type":"text","content":"\n\n\n\nCardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnsbls{\nBORDER-LEFT:black 1pt solid\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n.prnsbbs{\nBORDER-BOTTOM:black 1pt solid\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnrbrs{\nBORDER-RIGHT:black 1pt solid\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnsbts{\nBORDER-TOP:black 1pt solid\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n\n\n\n\n\n\nCardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores\nQ4 2017 Results Reflect Strong Product and Physician Acceptance\nPR Newswire\nHONOLULU, Feb. 17, 2018\n\n\n\nHONOLULU, Feb. 17, 2018 /PRNewswire/ -- Cardax, Inc. (OTCQB: CDXI) announced today that ZanthoSyn® (60 count), the Company's premium astaxanthin dietary supplement for inflammatory health and longevity, was the top selling product in Hawaii GNC stores for the fourth quarter of 2017, based on information provided to Cardax by GNC Holdings, Inc. (\"GNC\"). The product was first introduced in GNC's Hawaii stores in Q1 2017. \n\n\"Becoming the top selling, #1 product in GNC Hawaii so quickly is a significant milestone,\" said Gilbert Shin, Cardax Vice President, Retail Sales and Marketing.  \"This achievement reflects strong retail engagement by Hawaii GNC store personnel as well as strong product acceptance across a broad range of consumer demographics.\"\n\n\"We are very encouraged by the success of ZanthoSyn at GNC in Hawaii,\" added Cardax CEO David G. Watumull. \"Gil and his team have really demonstrated the viability of our sales and marketing strategy in Hawaii and we look forward to implementing this model nationwide.\"\n\nCardax recently announced that ZanthoSyn® became available at more than 3,000 GNC corporate stores in the U.S. in the fourth quarter of 2017. Cardax plans to drive ZanthoSyn® sales nationally through its two-pronged approach, modeled after Cardax's successful program in Hawaii: \n\n\nPhysician outreach and education, where ...